4
Changes in Ownership
ImmunityBio, Inc. Filed Acc 0001209191-18-034020
Director sold 6,003 shares at an average $3.94 ($23,668)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GORLIN STEVE Director | 2018-05-24 | Sale | −303 | $3.96 | $1,200 | 409,600 | I |
| GORLIN STEVE Director | 2018-05-25 | Sale | −3,400 | $3.97 | $13,498 | 406,200 | I |
| GORLIN STEVE Director | 2018-05-25 | Sale | −200 | $3.98 | $796 | 406,000 | I |
| GORLIN STEVE Director | 2018-05-29 | Sale | −1,500 | $3.89 | $5,835 | 404,500 | I |
| GORLIN STEVE Director | 2018-05-29 | Sale | −500 | $3.90 | $1,950 | 404,000 | I |
| GORLIN STEVE Director | 2018-05-29 | Sale | −100 | $3.90 | $390 | 403,900 | I |
| Open-market sales · 6,003 sh · avg $3.94 · $23,668 | |||||||
Loading xslF345X03/doc4.xml…